TrialHuman vaccines & immunotherapeutics2023

Safety and immunogenicity of a multivalent pneumococcal conjugate vaccine given with 13-valent pneumococcal conjugate vaccine in healthy infants: A phase 2 randomized trial.

Michael W Simon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.